Disclosures for "Comorbidities Associated With Plasma Neurofilament Light Chain and Glial Fibrillary Acidic Protein Levels Among People Living With HIV"
-
Dr. Beideck has nothing to disclose.
-
Miss Bachanova has received personal compensation for serving as an employee of Dartmouth College.
-
Ms. Rosen has nothing to disclose.
-
Ms. Park has nothing to disclose.
-
Dr. Kivisakk Webb has nothing to disclose.
-
Dr. Chow has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Medicolegal consulting. The institution of Dr. Chow has received research support from NIH.
-
Ms. Wu has nothing to disclose.
-
Dr. Rubin has nothing to disclose.
-
Dr. Tassiopoulos has nothing to disclose.
-
Dr. Parker has nothing to disclose.
-
The institution of Dr. Hyle has received research support from NIH. The institution of Dr. Hyle has received research support from MGH. Dr. Hyle has received publishing royalties from a publication relating to health care.
-
Dr. Mukerji has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Dynamed. Dr. Mukerji has or had stock in Gilead Science.Dr. Mukerji has or had stock in Ranpack.Dr. Mukerji has or had stock in Snowflake. An immediate family member of Dr. Mukerji has or had stock in Amgen. The institution of Dr. Mukerji has received research support from NIH. The institution of Dr. Mukerji has received research support from Massachusetts General Hospital.